文献速递血管炎其他结缔组织病

嗜酸性肉芽肿性多血管炎患者的心脏病变:一项筛查方法建议

Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该回顾性研究纳入131例EGPA患者,其中96例接受心血管评估。无症状患者中45%存在心脏评估异常,据此可提前诊断(4个月 vs 11个月)。EGPA相关炎症性心脏病患者更年轻、心电图异常更常见、BVAS评分及嗜酸性粒细胞计数和CRP更高。作者建议所有EGPA患者均应及早进行心脏筛查,而非仅按症状引导。

要点

  • 无症状EGPA患者中45%存在基线心脏评估异常,可提前诊断心脏病变。
  • EGPA相关炎症性心脏病患者心电图异常率30.8%显著高于无此病者的2.1%。
  • 建议所有EGPA患者及早心脏筛查,不采用仅症状引导的策略。

核心结论

  • 45%的无症状EGPA患者存在基线心脏评估异常,使心脏病变得以更早诊断。
  • 建议所有EGPA患者及早进行心脏筛查,而非仅按症状引导。

研究设计与样本

  • 回顾性研究,纳入1989-2016年就诊于专科血管炎门诊的131例EGPA患者。
  • 96例(73%)接受心血管评估,包括血清肌钙蛋白、心电图、超声心动图和心脏磁共振。

主要发现

  • 96例接受心血管评估的患者中43%有症状,以呼吸困难(47%)和胸痛(29%)为主。
  • 无症状患者中心血管评估异常占45%,其后续诊断时间较有症状者更早(4个月 vs 11个月)。
  • 27例存在EGPA相关炎症性心脏病(EGPA-rICD),其中20例诊断时已存在、2例先于诊断、5例 later 发生。
  • EGPA-rICD患者更年轻(46 vs 50岁;P=0.04)、心电图异常更常见(30.8% vs 2.1%;P<0.001)、BVAS评分更高(3 vs 1;P=0.005)、嗜酸性粒细胞计数更高(5.60 vs 1.60×10^9/l;P=0.029)、CRP更高(52 vs 15 mg/l;P=0.017)。
  • EGPA-rICD患者中11%无症状;ANCA阴性率85% vs 69%(无统计学显著性)。

关键数值与推荐

  • 心血管评估异常定义为血清肌钙蛋白、心电图、超声心动图或心脏磁共振任一异常。
  • EGPA-rICD诊断基于临床特征及心血管评估结果综合判断。
  • 推荐所有EGPA患者及早进行心脏筛查,替代症状引导的筛查策略。

临床怎么用

  • 对EGPA患者应尽早启动心脏筛查,包括心电图、超声心动图、肌钙蛋白和心脏磁共振。
  • 无症状患者也应进行基线心脏评估,以发现早期心脏受累并及时干预。
  • 年轻、心电图异常、高BVAS评分、高嗜酸性粒细胞计数或高CRP的EGPA患者需警惕合并炎症性心脏病。

局限性

  • 回顾性研究设计,存在选择偏倚和信息偏倚可能。
  • 单中心研究,样本量有限(131例),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define the pattern of cardiac involvement in eosinophilic granulomatosis and polyangiitis (EGPA) and propose an algorithm for heart disease screening. METHODS: This was a retrospective study of EGPA patients attending a specialized vasculitis clinic (1989-2016). Clinical characteristics and cardiovascular evaluation (CE) results (serum troponin, ECG, echocardiography and cardiac magnetic resonance) were collected and compared according to symptoms and inflammatory cardiac disease (ICD). RESULTS: A total of 131 EGPA patients were included, of whom 96 (73%) had undergone CE. The median (interquartile range) age was 50 (38-58) years and 36% showed ANCA+. Asthma preceded diagnosis by a median of 97 (36-240) months. Among the 96 patients who underwent CE, 43% were symptomatic, with dyspnea (47%) and chest pain (29%) being the predominant symptoms. In asymptomatic patients, CE reported abnormalities in 45% of cases, with a subsequent earlier diagnosis (4 vs 11 months). Overall, 27 patients had EGPA-related ICD (EGPA-rICD) that was already present at diagnosis in 20 cases, preceded it in 2 cases and developed later in 5 cases. EGPA-rICD patients were younger (46 vs 50 years; P = 0.04), had more frequently abnormal ECG (30.8 vs 2.1%; P < 0.001), negative ANCA (85 vs 69%; NS), higher BVAS score (3 vs 1; P = 0.005), higher eosinophil count (5.60 vs 1.60 × 109/l; P = 0.029) and higher CRP (52 vs 15 mg/l; P = 0.017). Overall, 11% of cases with EGPA-rICD were asymptomatic. CONCLUSION: In our study, 45% of asymptomatic patients had an abnormal baseline cardiac evaluation, which allowed an earlier diagnosis of cardiac disease. We recommend prompt cardiac screening in all EGPA patients, instead of a symptoms-guided algorithm.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Garcia-Vives E, Rodriguez-Palomares JF, Harty L, et al. Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal. Rheumatology (Oxford). 2021. PMID: 33493294. doi:10.1093/rheumatology/keab027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。